Penn & Seaborn Summer 2017 Client Newsletter

Summer is upon us. Stay safe this summer with our summer safety tips. And learn more about the current cases we are working on, recent verdicts and settlements, and more in our Summer 2017 Client Newsletter. Subscribe to our Free Newsletter The Penn and Seaborn Client Newsletter is a free quarterly newsletter designed to help keep you informed of important consumer safety issues. Subscribe Today

Serious safety issues continue to plague blood thinner Xarelto

Lawsuits filed against Johnson & Johnson subsidiary Janssen Pharmaceuticals and Bayer Corp. over the blood thinner Xarelto have been consolidated in Louisiana federal court. Xarelto has been linked to serious side effects including internal bleeding, gastrointestinal bleeding, brain bleed and death. The Xarelto lawsuits come on the heels of the recent $650 million Pradaxa settlement. Researchers linked Pradaxa, also a blood thinning medication, to more

By | April 12th, 2016|Dangerous Drugs|

Xarelto found to cause serious and irreversible bleeding

Penn & Seaborn is currently evaluating several lawsuits against Xarelto. We are currently filing lawsuits on behalf of individuals who experienced severe bleeding while taking Xarelto. If you or a loved one was hospitalized due to bleeding while taking Xarelto, please contact us today for a free lawsuit evaluation. What is Xarelto? Xarelto (rivaroxaban) is a prescription medicine that acts as an anticoagulant (blood thinner) to

By | March 2nd, 2016|Class Action Lawsuits, Dangerous Drugs|

Missouri jury awards $72M in Johnson & Johnson cancer suit

A Missouri jury has awarded $72 million to the family of an Alabama woman who died from ovarian cancer, which she said was caused by using Johnson & Johnson’s well-known baby powder and other products containing talcum. The civil suit by Jackie Fox of Birmingham was part of a broader claim in the city of St. Louis Circuit Court involving nearly 60 people. Her son

By | February 27th, 2016|Class Action Lawsuits, Dangerous Drugs, Product Liability|